Full Issue

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Sep/Oct 2011 - Volume 15, Number 5

Purchase the entire back issue in electronic PDF or print format.

(Select Format)

Purchase individual articles by selecting the article in the table below...

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Individual Articles - Sep/Oct 2011 - Volume 15, Number 5
PreScription: Third-party Inequities and Discrimination Allen Loyd V Jr	Sep/Oct 2011 Pg. 356
PreScription: American Pharmacists Month: A Time for Taking Responsibility Menighan Thomas E	Sep/Oct 2011 Pg. 356
Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride Zur Eyal	Sep/Oct 2011 Pg. 358-366
Natural Tragedies: Planning for Disasters and Emergencies Williams LaVonn A	Sep/Oct 2011 Pg. 368-371
Lessons Learned from a Continuous Quality-Improvement Testing Program McElhiney Linda F	Sep/Oct 2011 Pg. 372-374
Magic Mouthwashes: A Literature Review and Discussion of Common Compositions McElhiney Linda F	Sep/Oct 2011 Pg. 376-380
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Miller David	Sep/Oct 2011 Pg. 382-384
Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient McElhiney Linda F	Sep/Oct 2011 Pg. 386-387
7 Marketing Tactics That Don't Work Moore Renee	Sep/Oct 2011 Pg. 388-389
Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons James Kate, Allred Richard, Latta Kenneth S, McElhiney Linda F, Olson Jacob, Hall Richard M, Baker Chad, Armstrong Nicholas, Janik Peter, Whitehead Paul, Purcell Julian	Sep/Oct 2011 Pg. 390-407
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2 Allen Loyd V Jr	Sep/Oct 2011 Pg. 408-414
Calculations Stockton Shelly J	Sep/Oct 2011 Pg. 416
Carvedilol 0.625-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2011 Pg. 418
Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 419
Lorazepam 1-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 420
Metoprolol Tartrate 1.25-mg/mL Oral Liquid Allen Loyd V Jr	Sep/Oct 2011 Pg. 421
Nifedipine 1-mg/500-mg Oral Powder Allen Loyd V Jr	Sep/Oct 2011 Pg. 422
Nifedipine 10-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 423
Rebamipide Rectal Enema Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 424
Sotalol 5-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 425
Sulfadiazine 100-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 426
Ursodiol 50-mg/mL Oral Suspension Allen Loyd V Jr	Sep/Oct 2011 Pg. 427
Study of Microbiological Safety of 25 Oncology Drugs After Multiple Uses in Aseptic Conditions Roy Julie, Brault Julie, Joran Pierre, Metrop Raphael, Hildgen Patrice	Sep/Oct 2011 Pg. 428-434
Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations Yamreudeewong Weeranuj, Dolence Eric Kurt, Teixeira M Glaucia	Sep/Oct 2011 Pg. 435-437
PostScription: Compounders Go Above and Beyond in the Name of Safety Gates Ernest P Jr	Sep/Oct 2011 Pg. 438-439
Return to Top

	PDF — $95
	Print Copy — $95